Neuroleptic malignant syndrome in children and adolescents

Journal of Child Neurology

Volumn 16, Issue 3, 2001, Pages 157-163

  Ty, Edna B ^a   Rothner, A David ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; BROMOCRIPTINE; BROMPERIDOL; CHLORPROMAZINE; CREATINE KINASE; DANTROLENE; DIPHENHYDRAMINE; DROPERIDOL; FENTANYL; FLUPHENAZINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; IMIPRAMINE; LEVODOPA; LITHIUM; LORAZEPAM; LOXAPINE; METOCLOPRAMIDE; NEUROLEPTIC AGENT; PERPHENAZINE; PROMETHAZINE; PROPOFOL; RISPERIDONE; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE; UNINDEXED DRUG; VALPROIC ACID;

ADOLESCENT; ADULT; AGITATION; ANXIETY NEUROSIS; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DYSTONIA; EARLY DIAGNOSIS; FATALITY; FEMALE; FEVER; HALLUCINATION; HOSPITAL ADMISSION; HUMAN; MALE; MEDICAL LITERATURE; MORBIDITY; MORTALITY; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; PARANOID PSYCHOSIS; PATHOGENESIS; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; RISK FACTOR; SCHIZOIDISM; SEDATION; SUICIDE ATTEMPT; TREATMENT OUTCOME; TREMOR;

EID: 0035025971     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380101600301     Document Type: Review

References (46)

1. Caroff S, Rosenberg H, Gerber JC: Neuroleptic malignant syndrome and hyperthermia. J Clin Psychopharmacol 1983;3:120-121.
2. Pope HG, Keck PE, McElroy SL: Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry 1986;143:1227-1233.
3. American Psychiatric Association: Diagnostic and Statistical Manual for Mental Disorders, 4th ed. Washington, DC, APA, 1994.
4. Hunter R: Dangerous drugs. Nurs Times 1989;85:42-44.
5. Susman V, Addonizio G: Recurrence of neuroleptic malignant syndrome. J Nerv Ment Dis 1988;176:234-241.
6. Bristow MF, Kohen D: How "malignant" is the neuroleptic malignant syndrome? BMJ 1993;307:1223-1224.
7. Bertorini T: Myoglobinuria, malignant hyperthermia, neuroleptic malignant syndrome and serotonin syndrome. Neurol Clin 1997;15:649-971.
8. Addonizio G, Susman V, Roth S: Neuroleptic malignant syndrome: Review and analysis of 115 cases. Biol Psychiatry 1987;22:1004-1020.
9. Moyes DJ: Malignant hyperpyrexia caused by trimeprazine. Br J Anaesth 1973;45:1163-1164.
10. Itoh H, Ohtsuka N, Ogita K: Neuroleptic malignant syndrome: Its present status in Japan and clinical problems. Folia Psych Neurol (Japonica) 1977;31:567-576.
11. Geller B, Greydanus D: Haloperidol-induced comatose state with hyperthermia and rigidity in adolescence: 2 case reports with a literature review. J Clin Psychiatry 1979;40:102-103.
12. Grunhaus L, Sancovici S, Rimon R: Neuroleptic malignant syndrome due to depot fluphenazine. Clin Psychiatry 1979;40:99-100.
13. Ries RK, Schuckit MA: Catalonia and autonomie hyperactivity. Psychosomatics 1980;21:349-350.
14. Goulan M, de Rohan-Chabot PD, Elkharrat D: Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: A report of two cases. Neurology 1983;33:516-518.
15. Klein SK, Levinsohn MW, Blumer JL: Accidental chlorpromazine ingestion as a cause of neuroleptic malignant syndrome in children. J Pediatr 1985;107:970-973.
16. Verhoeven WM, Elderson A, Westenberg HG: Neuroleptic malignant syndrome: Successful treatment with bromocriptine. Biol Psychiatry 1985;20:680-684.
17. Tenenbien M: Neuroleptic malignant syndrome: Occurrence in a 15 year old boy and recovery with bromocriptine therapy. Pediatr Neurosci 1985-1986;12:161-164.
18. Merry SN, Werry JS, Merry AF, Birchall N: The neuroleptic malignant syndrome in an adolescent. J Am Acad Child Psychiatry 1986;25:284-286.
19. Moor A, O'Donohoe N, Monaghan H: Neuroleptic malignant syndrome. Arch Dis Child 1986;61:793-795.
20. Diamond JM, Hayes DD: A case of neuroleptic malignant syndrome in a mentally retarded adolescent. J Adolesc Health Care 1986;7:419-422.
21. Dhib-Jalbut S, Hesselbrock R, Mouradian MM, Means ED: Bromocriptine treatment of neuroleptic malignant syndrome. J Clin Psychiatry 1987;48:69-73.
22. Harsh HH: Neuroleptic malignant syndrome: Physiological and laboratory findings in a series of nine cases. J Clin Psychiatry 1987;48:328-333.
23. Keck PE. Pope HG, McElroy SL: Frequency and presentation of neuroleptic malignant syndrome: A prospective study. Am J Psychiatry 1987:144:1344-1346.
24. Walker WD: Spectrum concept of neuroleptic malignant syndrome. Br J Psychiatry 1988;153:574.
25. Akari M, Tkagi A, Higuchi I, Sugita H: Neuroleptic malignant syndrome: Caffeine contracture of single muscle fibers and muscle pathology. Neurology 1988;38:297-301.
26. Bhatia MS, Singhal PK, Bohra N, Kaur N: Neuroleptic malignant syndrome. Pediatrics 1988;25:788-790.
27. Carden PA, Mitchell SL: Acute psychosis plus neuroleptic malignant syndrome as complications of therapy in an adolescent with acute lymphoblastic leukemia. Aust J Hosp Pharmacol 1988;18:205-207.
28. Guerrero RM, Shifrar KA: Diagnosis and treatment of neuroleptic malignant syndrome. Clin Pharmacol 1988;7:697-701.
29. Kaponen H, Repo E, Lepola U: Neuroleptic malignant syndrome. Biol Psychiatry 1988;24:941-960.
30. Kontaxakis V, Stefanis C, Markidis M, Tserpe V: Neuroleptic malignant syndrome in a patient with Wilson's disease. J Neurol Neurosurg Psychiatry 1988;51:1001-1002.
31. Padgett R, Lipman E: Use of neuroleptics after an episode of neuroleptic malignant syndrome. Can J Psychiatry 1989;34:323-325.
32. Rosebush P, Stewart T: A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J Psychiatry 1989; 146:717-725.
33. Brown FE, Nierenberg DW, Nordgren RE: Neuroleptic malignant syndrome: Occurrence in a child after reconstructive surgery. Plast Reconstr Surg 1991;87:961-964.
34. Joshi PT, Capozzoli JA, Coyle JT: Neuroleptic malignant syndrome: Life-threatening complication of neuroleptic treatment in an adolescents with affective disorder. Pediatrics 1991;87:235-239.
35. Numa A. Neuroleptic malignant syndrome in children. Med J Aust 1991;155:417-419.
36. Steingard R, Khan A, Gonzalez A, Herzog DB: Neuroleptic malignant syndrome: Review of experience with children and adolescents. J Child Adolesc Psychopharmacol 1992;2:183-198.
37. Latz S, McCracken J: Neuroleptic malignant syndrome in children and adolescents: 2 case reports and a warning. J Child Adolesc Psychopharmacol 1992;2:123-129.
38. Shaw A, Matthews E: Post-operative neuroleptic malignant syndrome. Anaesthesia 1995;50:246-247.
39. Peterson S, Myers KM, McClellan J, Crow S: Neuroleptic malignant syndrome: 3 adolescents with complicated courses. J Child Adolesc Psychopharmacol 1995;5:139-149.
40. Unal F, Hizli S, Ozyurek H: Fever and altered consciousness are not always equal to central nervous system infection: Neuroleptic malignant syndrome in a 15 year old girl. Turk J Pediatr 1996;38:505-510
41. Addonizio G, Susman V, Roth S: Symptoms of neuroleptic malignant syndrome in consecutive in-patients. Am J Psychiatry 1986;143:1587-1590.
42. Ebadi M, Srinivasan SK: Pathogenesis, prevention and treatment of neuroleptic induced movement disorder. Pharmacol Rev 1995;47:575-604.
43. Fink M: Toxic serotonin syndrome or neuroleptic malignant syndrome? Pharmacopsychiatry 1996;29:159-161.
44. Sachdev P, Mason C, Hadzi-Pavlovic D: Case-control study of neuroleptic malignant syndrome. Am J Psychiatry 1997;154:1156-1158.
45. Buckley P, Hatchinson M: Neuroleptic malignant syndrome. J Neurol Neurosurg Psychiatry 1995;58:271-273.
46. Ram A, Cao Q, Keck PE Jr, et al: Structural change in dopamine D2 receptor gene in a patient with neuroleptic malignant syndrome. Am J Med Genet 1995;60:228-230.